Article Versions Notes

Inoue A, Ohnishi T, Nishikawa M, Watanabe H, Kusakabe K, Taniwaki M, Yano H, Ohtsuka Y, Matsumoto S, Suehiro S, et al. Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence. Biomedicines. 2023; 11(9):2369. https://doi.org/10.3390/biomedicines11092369

Inoue, Akihiro, Takanori Ohnishi, Masahiro Nishikawa, Hideaki Watanabe, Kosuke Kusakabe, Mashio Taniwaki, Hajime Yano, Yoshihiro Ohtsuka, Shirabe Matsumoto, Satoshi Suehiro, and et al. 2023. "Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence" Biomedicines 11, no. 9: 2369. https://doi.org/10.3390/biomedicines11092369

Inoue, A., Ohnishi, T., Nishikawa, M., Watanabe, H., Kusakabe, K., Taniwaki, M., Yano, H., Ohtsuka, Y., Matsumoto, S., Suehiro, S., Yamashita, D., Shigekawa, S., Takahashi, H., Kitazawa, R., Tanaka, J., & Kunieda, T. (2023). Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence. Biomedicines, 11(9), 2369. https://doi.org/10.3390/biomedicines11092369